Candida albicans Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB) Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01151189Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
NCT01650389Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination